Genetically engineered T cell and tumour-infiltrating lymphocyte therapies

Genetically engineered T cell and tumour-infiltrating lymphocyte therapies

Haemato-oncology has made significant progress in recent years, particularly through the development of innovative immunotherapeutic approaches such as CAR T cell (chimeric antigen receptor T cell) and tumour-infiltrating lymphocyte therapies. Both methods use the patient’s own immune system to trea...

Full description

Saved in:
Bibliographic Details
Main Authors: Heinz Läubli, Andreas Holbro
Format: Article
Language:English
Published: SMW supporting association (Trägerverein Swiss Medical Weekly SMW) 2025-07-01
Series:Swiss Medical Weekly
Online Access:https://smw.ch/index.php/smw/article/view/4279
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items